Active intestinal chloride secretion in human carriers of cystic fibrosis mutations

An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion

C. Hogenauer, C. A. Santa Ana, J. L. Porter, M. Millard, A. Gelfand, R. L. Rosenblatt, C. B. Prestidge, J. S. Fordtran

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

To explain the very high frequency of cystic fibrosis (CF) mutations in most populations of European descent, it has been proposed that CF heterozygotes have a survival advantage when infected with Vibrio cholerae or Escherichia coli, the toxins of which induce diarrhea by stimulation of active intestinal chloride secretion. Two assumptions underlie this hypothesis: (1) chloride conductance by the CF transmembrane conductance regulator (CFTR) is the rate-limiting step for active intestinal chloride secretion at all levels of expression, from approximately zero in patients with CF to normal levels in people who are not carriers of a mutation; and (2) heterozygotes have smaller amounts of functional intestinal CFTR than do people who are not carriers, and heterozygotes therefore secrete less chloride when exposed to secretagogues. The authors used an intestinal perfusion technique to measure in vivo basal and prostaglandin-stimulated jejunal chloride secretion in normal subjects, CF heterozygotes, and patients with CF. Patients with CF had essentially no active chloride secretion in the basal state, and secretion was not stimulated by a prostaglandin analogue. However, CF heterozygotes secreted chloride at the same rate as did people without a CF mutation. If heterozygotes are assumed to have less-than-normal intestinal CFTR function, these results mean that CFTR expression is not rate limiting for active chloride secretion in heterozygotes. The results do not support the theory that the very high frequency of CF mutations is due to a survival advantage that is conferred on heterozygotes who contract diarrheal illnesses mediated by intestinal hypersecretion of chloride.

Original languageEnglish (US)
Pages (from-to)1422-1427
Number of pages6
JournalAmerican Journal of Human Genetics
Volume67
Issue number6
DOIs
StatePublished - 2000

Fingerprint

Intestinal Secretions
Heterozygote
Cystic Fibrosis
Chlorides
Mutation
Synthetic Prostaglandins
Cystic Fibrosis Transmembrane Conductance Regulator
Vibrio cholerae
Survival
Prostaglandins
Diarrhea
Perfusion
Escherichia coli

ASJC Scopus subject areas

  • Genetics

Cite this

Active intestinal chloride secretion in human carriers of cystic fibrosis mutations : An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. / Hogenauer, C.; Santa Ana, C. A.; Porter, J. L.; Millard, M.; Gelfand, A.; Rosenblatt, R. L.; Prestidge, C. B.; Fordtran, J. S.

In: American Journal of Human Genetics, Vol. 67, No. 6, 2000, p. 1422-1427.

Research output: Contribution to journalArticle

Hogenauer, C. ; Santa Ana, C. A. ; Porter, J. L. ; Millard, M. ; Gelfand, A. ; Rosenblatt, R. L. ; Prestidge, C. B. ; Fordtran, J. S. / Active intestinal chloride secretion in human carriers of cystic fibrosis mutations : An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. In: American Journal of Human Genetics. 2000 ; Vol. 67, No. 6. pp. 1422-1427.
@article{afef94043df2427f95003c6acf6005f6,
title = "Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion",
abstract = "To explain the very high frequency of cystic fibrosis (CF) mutations in most populations of European descent, it has been proposed that CF heterozygotes have a survival advantage when infected with Vibrio cholerae or Escherichia coli, the toxins of which induce diarrhea by stimulation of active intestinal chloride secretion. Two assumptions underlie this hypothesis: (1) chloride conductance by the CF transmembrane conductance regulator (CFTR) is the rate-limiting step for active intestinal chloride secretion at all levels of expression, from approximately zero in patients with CF to normal levels in people who are not carriers of a mutation; and (2) heterozygotes have smaller amounts of functional intestinal CFTR than do people who are not carriers, and heterozygotes therefore secrete less chloride when exposed to secretagogues. The authors used an intestinal perfusion technique to measure in vivo basal and prostaglandin-stimulated jejunal chloride secretion in normal subjects, CF heterozygotes, and patients with CF. Patients with CF had essentially no active chloride secretion in the basal state, and secretion was not stimulated by a prostaglandin analogue. However, CF heterozygotes secreted chloride at the same rate as did people without a CF mutation. If heterozygotes are assumed to have less-than-normal intestinal CFTR function, these results mean that CFTR expression is not rate limiting for active chloride secretion in heterozygotes. The results do not support the theory that the very high frequency of CF mutations is due to a survival advantage that is conferred on heterozygotes who contract diarrheal illnesses mediated by intestinal hypersecretion of chloride.",
author = "C. Hogenauer and {Santa Ana}, {C. A.} and Porter, {J. L.} and M. Millard and A. Gelfand and Rosenblatt, {R. L.} and Prestidge, {C. B.} and Fordtran, {J. S.}",
year = "2000",
doi = "10.1086/316911",
language = "English (US)",
volume = "67",
pages = "1422--1427",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - Active intestinal chloride secretion in human carriers of cystic fibrosis mutations

T2 - An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion

AU - Hogenauer, C.

AU - Santa Ana, C. A.

AU - Porter, J. L.

AU - Millard, M.

AU - Gelfand, A.

AU - Rosenblatt, R. L.

AU - Prestidge, C. B.

AU - Fordtran, J. S.

PY - 2000

Y1 - 2000

N2 - To explain the very high frequency of cystic fibrosis (CF) mutations in most populations of European descent, it has been proposed that CF heterozygotes have a survival advantage when infected with Vibrio cholerae or Escherichia coli, the toxins of which induce diarrhea by stimulation of active intestinal chloride secretion. Two assumptions underlie this hypothesis: (1) chloride conductance by the CF transmembrane conductance regulator (CFTR) is the rate-limiting step for active intestinal chloride secretion at all levels of expression, from approximately zero in patients with CF to normal levels in people who are not carriers of a mutation; and (2) heterozygotes have smaller amounts of functional intestinal CFTR than do people who are not carriers, and heterozygotes therefore secrete less chloride when exposed to secretagogues. The authors used an intestinal perfusion technique to measure in vivo basal and prostaglandin-stimulated jejunal chloride secretion in normal subjects, CF heterozygotes, and patients with CF. Patients with CF had essentially no active chloride secretion in the basal state, and secretion was not stimulated by a prostaglandin analogue. However, CF heterozygotes secreted chloride at the same rate as did people without a CF mutation. If heterozygotes are assumed to have less-than-normal intestinal CFTR function, these results mean that CFTR expression is not rate limiting for active chloride secretion in heterozygotes. The results do not support the theory that the very high frequency of CF mutations is due to a survival advantage that is conferred on heterozygotes who contract diarrheal illnesses mediated by intestinal hypersecretion of chloride.

AB - To explain the very high frequency of cystic fibrosis (CF) mutations in most populations of European descent, it has been proposed that CF heterozygotes have a survival advantage when infected with Vibrio cholerae or Escherichia coli, the toxins of which induce diarrhea by stimulation of active intestinal chloride secretion. Two assumptions underlie this hypothesis: (1) chloride conductance by the CF transmembrane conductance regulator (CFTR) is the rate-limiting step for active intestinal chloride secretion at all levels of expression, from approximately zero in patients with CF to normal levels in people who are not carriers of a mutation; and (2) heterozygotes have smaller amounts of functional intestinal CFTR than do people who are not carriers, and heterozygotes therefore secrete less chloride when exposed to secretagogues. The authors used an intestinal perfusion technique to measure in vivo basal and prostaglandin-stimulated jejunal chloride secretion in normal subjects, CF heterozygotes, and patients with CF. Patients with CF had essentially no active chloride secretion in the basal state, and secretion was not stimulated by a prostaglandin analogue. However, CF heterozygotes secreted chloride at the same rate as did people without a CF mutation. If heterozygotes are assumed to have less-than-normal intestinal CFTR function, these results mean that CFTR expression is not rate limiting for active chloride secretion in heterozygotes. The results do not support the theory that the very high frequency of CF mutations is due to a survival advantage that is conferred on heterozygotes who contract diarrheal illnesses mediated by intestinal hypersecretion of chloride.

UR - http://www.scopus.com/inward/record.url?scp=0033646566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033646566&partnerID=8YFLogxK

U2 - 10.1086/316911

DO - 10.1086/316911

M3 - Article

VL - 67

SP - 1422

EP - 1427

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 6

ER -